Fermenta Biotech Ltd.

BOM:FERMENTAHealthcare

——At close · Market cap — · Next earnings Sat 14 Nov

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	3.7	4.0	3.5	3.3	4.7	5.2	+11.6%
Cost of revenue	1.4	3.0	2.9	1.5	1.5	3.0	+101.0%
Gross profit	1.1	1.0	0.6	0.7	3.2	2.3	−29.3%
Research & development	0.1	0.1	0.1	0.1	0.1	0.0	−100.0%
Selling, general & administrative	0.6	0.5	0.3	0.6	0.3	1.5	+366.6%
Selling & marketing	0.0	0.0	0.1	0.0	0.2	0.0	−100.0%
Operating expenses	0.6	0.6	0.7	0.8	2.4	1.5	−36.1%
Operating income	1.7	0.4	(0.1)	0.0	0.9	0.8	−10.6%
Interest expense	0.2	0.2	0.2	0.2	0.1	0.1	−18.7%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	(1.2)	(0.1)	(0.4)	(0.2)	(0.0)	0.2	+915.3%
Pre-tax income	0.5	0.3	(0.5)	(0.1)	0.8	1.0	+15.2%
Income tax	0.1	0.1	0.0	0.1	0.1	0.3	+276.3%
Net income	0.5	0.2	(0.5)	(0.2)	0.8	0.7	−6.6%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	15.77	5.35	(17.70)	(7.99)	26.47	24.70	−6.7%
EPS, diluted (per share)	15.69	5.33	(17.70)	(7.99)	26.47	24.51	−7.4%
EBITDA	0.9	0.7	(0.0)	0.3	1.2	1.0	−19.3%
Depreciation & amortization	0.2	0.3	0.3	0.2	0.2	0.2	−10.4%
Weighted average shares (shares)	28,847,322	28,847,322	28,857,303	28,860,826	29,041,385	29,055,000	+0.0%
Weighted average diluted shares (shares)	29,004,786	29,002,333	28,857,303	28,874,107	29,041,385	29,280,000	+0.8%
Gross margin	30.6%	25.0%	17.6%	20.4%	68.6%	43.4%	−25.2 pts
Operating margin	45.0%	9.3%	−2.0%	1.1%	18.2%	14.6%	−3.6 pts
Net margin	12.2%	3.9%	−14.6%	−6.9%	16.4%	13.7%	−2.7 pts

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.